Seagen Inc. buy BiotechBee
Start price
07.09.22
/
60%
€152.08
Target price
31.12.24
€180.00
Performance (%)
21.00%
End price
21.03.23
€184.02
Summary
This prediction ended on 21.03.23 with a price of €184.02. The prediction had a final performance of 21.00%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Seagen Inc. | - | - | - | - |
| iShares Core DAX® | -0.197% | -1.724% | 12.342% | 55.750% |
| iShares Nasdaq 100 | -3.612% | -3.768% | 0.437% | 80.820% |
| iShares Nikkei 225® | 1.176% | 2.165% | 19.971% | 49.596% |
| iShares S&P 500 | -0.825% | -1.916% | 0.099% | 55.940% |
According to BiotechBee what are the pros and cons of Seagen Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Seagen Inc. diskutieren
Buy mit Kursziel 180,0